296 related articles for article (PubMed ID: 19413341)
1. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
Surace C; Arpicco S; Dufaÿ-Wojcicki A; Marsaud V; Bouclier C; Clay D; Cattel L; Renoir JM; Fattal E
Mol Pharm; 2009; 6(4):1062-73. PubMed ID: 19413341
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.
Dufaÿ Wojcicki A; Hillaireau H; Nascimento TL; Arpicco S; Taverna M; Ribes S; Bourge M; Nicolas V; Bochot A; Vauthier C; Tsapis N; Fattal E
J Control Release; 2012 Sep; 162(3):545-52. PubMed ID: 22820451
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
4. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
Maitani Y; Igarashi S; Sato M; Hattori Y
Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
[TBL] [Abstract][Full Text] [Related]
5. Positive hyaluronan/PEI/DNA complexes as a target-specific intracellular delivery to malignant breast cancer.
Sun X; Ma P; Cao X; Ning L; Tian Y; Ren C
Drug Deliv; 2009 Oct; 16(7):357-62. PubMed ID: 19545193
[TBL] [Abstract][Full Text] [Related]
6. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
[TBL] [Abstract][Full Text] [Related]
7. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
8. Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency.
Zuhorn IS; Bakowsky U; Polushkin E; Visser WH; Stuart MC; Engberts JB; Hoekstra D
Mol Ther; 2005 May; 11(5):801-10. PubMed ID: 15851018
[TBL] [Abstract][Full Text] [Related]
9. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
10. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
[TBL] [Abstract][Full Text] [Related]
11. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency.
Esposito C; Generosi J; Mossa G; Masotti A; Castellano AC
Colloids Surf B Biointerfaces; 2006 Dec; 53(2):187-92. PubMed ID: 17049213
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
13. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery.
Yin H; Zhao F; Zhang D; Li J
Int J Pharm; 2015 Apr; 483(1-2):169-79. PubMed ID: 25681725
[TBL] [Abstract][Full Text] [Related]
15. Correlation between structure and transfection efficiency: a study of DC-Chol--DOPE/DNA complexes.
Congiu A; Pozzi D; Esposito C; Castellano C; Mossa G
Colloids Surf B Biointerfaces; 2004 Jul; 36(1):43-8. PubMed ID: 15261022
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid.
Boussif O; Gaucheron J; Boulanger C; Santaella C; Kolbe HV; Vierling P
J Gene Med; 2001; 3(2):109-14. PubMed ID: 11318109
[TBL] [Abstract][Full Text] [Related]
17. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
18. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and transfection activity of new cationic phosphoramidate lipids: high efficiency of an imidazolium derivative.
Mével M; Breuzard G; Yaouanc JJ; Clément JC; Lehn P; Pichon C; Jaffrès PA; Midoux P
Chembiochem; 2008 Jun; 9(9):1462-71. PubMed ID: 18454443
[TBL] [Abstract][Full Text] [Related]
20. In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids.
Gaucheron J; Boulanger C; Santaella C; Sbirrazzuoli N; Boussif O; Vierling P
Bioconjug Chem; 2001; 12(6):949-63. PubMed ID: 11716686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
